We describe a child with acute myeloid leukemia (AML) who developed severe central sleep apnea (CSA) on methadone therapy for chronic pain management. His chemotherapy-related cerebral atrophy and renal insufficiency with impaired methadone clearance may have also contributed to the severity of his sleep-disordered breathing. Maintenance methadone treatment is not a common pediatric practice; therefore, the adverse effects of methadone therapy, including CSA, are rarely reported in children.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/ppul.22539 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!